Picture of cbdMD logo

YCBD cbdMD Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Annual cashflow statement for cbdMD, fiscal year end - September 30th, USD millions except per share, conversion factor applied.

2020
September 30th
2021
September 30th
2022
September 30th
2023
September 30th
2024
September 30th
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line12.6-23.4-70.1-22.9-3.7
Depreciation
Amortisation
Deferred Taxes
Non-Cash Items-24.311.156.116.32.66
Discontinued Operations
Unusual Items
Other Non-Cash Items
Changes in Working Capital1.7-1.93-2.770.57-0.463
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities-10.7-14.1-15-4.3-0.353
Capital Expenditures-1.32-0.342-0.689-0.298-0.29
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-0.25-2.21010
Acquisition of Business
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-1.57-2.55-0.6890.702-0.29
Financing Cash Flow Items0.06200
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities22.428.2-4.04-1.321.3
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash10.111.6-19.7-4.920.655